Found: 11
Select item for more details and to access through your institution.
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 318, doi. 10.1002/ajh.24269
- By:
- Publication type:
- Article
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 542, doi. 10.1002/ajh.23685
- By:
- Publication type:
- Article
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1‐negative Myeloproliferative Neoplasms Latium Group".
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 335, doi. 10.1111/ejh.13454
- By:
- Publication type:
- Article
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 5, p. 673, doi. 10.1111/bjh.12168
- By:
- Publication type:
- Article
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 404, doi. 10.1002/cncr.26194
- By:
- Publication type:
- Article
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2596, doi. 10.3390/jcm11092596
- By:
- Publication type:
- Article
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 8, p. 1413, doi. 10.1007/s00277-014-2053-9
- By:
- Publication type:
- Article
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article